12 Health Care Stocks Moving In Friday's Pre-Market Session

Actuate Therapeutics, Inc.
AN2 Therapeutics, Inc.
Corvus Pharmaceuticals, Inc.
Enveric Biosciences, Inc.
Harvard Bioscience, Inc.

Actuate Therapeutics, Inc.

ACTU

0.00

AN2 Therapeutics, Inc.

ANTX

0.00

Corvus Pharmaceuticals, Inc.

CRVS

0.00

Enveric Biosciences, Inc.

ENVB

0.00

Harvard Bioscience, Inc.

HBIO

0.00

Gainers

  • Psyence Biomedical (NASDAQ:PBM) stock rose 77.2% to $10.4 during Friday's pre-market session. The company's market cap stands at $6.0 million.
  • iSpecimen (NASDAQ:ISPC) stock rose 34.76% to $0.16. The company's market cap stands at $3.4 million.
  • Corvus Pharmaceuticals (NASDAQ:CRVS) shares increased by 14.69% to $17.25. The company's market cap stands at $1.2 billion.
  • AN2 Therapeutics (NASDAQ:ANTX) shares increased by 14.33% to $3.59. The company's market cap stands at $112.8 million.
  • Kura Oncology (NASDAQ:KURA) shares rose 12.75% to $10.08. The company's market cap stands at $793.5 million.
  • Beyond Air (NASDAQ:XAIR) shares moved upwards by 12.33% to $0.5. The market value of their outstanding shares is at $4.6 million.

Losers

  • Enveric Biosciences (NASDAQ:ENVB) shares fell 16.2% to $1.97 during Friday's pre-market session. The company's market cap stands at $3.2 million.
  • Harvard Bioscience (NASDAQ:HBIO) stock fell 10.16% to $5.31. The market value of their outstanding shares is at $26.4 million.
  • Trevi Therapeutics (NASDAQ:TRVI) shares declined by 8.88% to $13.25. The company's market cap stands at $1.8 billion.
  • Actuate Therapeutics (NASDAQ:ACTU) shares fell 8.87% to $1.96. The market value of their outstanding shares is at $50.9 million.
  • Propanc Biopharma (NASDAQ:PPCB) shares decreased by 8.0% to $0.1. The company's market cap stands at $2.3 million.
  • Hoth Therapeutics (NASDAQ:HOTH) stock declined by 7.43% to $0.69. The company's market cap stands at $14.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.